New research shows people who had COVID-19 at greater risk of developing Type 2 diabetes
People who have had COVID-19 are at a greater risk of developing Type 2 diabetes within a year compared with those who have not been infected, new research published Monday in the journal Lancet Diabetes and Endocrinology shows.
Researchers reviewed the records of more than 181,000 Department of Veterans Affairs patients who were diagnosed with COVID-19 between March 1, 2020, and Sept. 30, 2021, and compared them to records from more than 4.1 million VA patients who were not infected during the same period plus 4.28 million others who received medical care from the VA in 2018 and 2019.
The researchers calculated that individuals diagnosed with COVID-19 were 46 percent more likely to develop Type 2 diabetes for the first time or have a doctor prescribe medicine to control their blood sugar, The Washington Post reports. The elevated risk affected people who had mild or asymptomatic cases, and went up for those who experienced severe COVID symptoms.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This study does not prove cause and effect, but rather a strong association between COVID-19 and Type 2 diabetes, the Post notes. While VA patients tend to be older, with more men and white people represented, "the risk was evident in all subgroups," said Ziyad Al-Aly of the VA St. Louis Health Care System, who led the review. Because of that, he is telling anyone who has had COVID-19 to "pay attention to your blood sugar." Read more at The Washington Post.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts



